Rockefeller Capital Management’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Other funds holding ATNM
Rockefeller Capital Management's ATNM Position: Q3 2026 in Review
Rockefeller Capital Management held its Actinium Pharmaceuticals (ATNM) position steady in Q3 2026 at 4,000 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #4411.
Rockefeller Capital Management first reported a position in ATNM in Q1 2020 and has held it in 19 quarters since. The position peaked at $160K in Q4 2022. 50 funds tracked by Wall St. Rank hold ATNM as of Q3 2026.
- Rockefeller Capital Management held 4,000 shares of Actinium Pharmaceuticals worth $4.48K as of Q3 2026.
- Rockefeller Capital Management left its Actinium Pharmaceuticals share count unchanged in Q3 2026.
- Actinium Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4411 holding.
- Rockefeller Capital Management first reported a position in Actinium Pharmaceuticals in Q1 2020 and has held it in 19 quarters since.
- Rockefeller Capital Management's Actinium Pharmaceuticals position peaked at $160K in Q4 2022.
- 50 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.